Ovid Therapeutics Inc’s filing revealed that its President and COO ALEXANDER MARGARET A. unloaded Company’s shares for reported $2956.0 on Feb 26 ’25. In the deal valued at $0.56 per share,5,279 shares were sold. As a result of this transaction, ALEXANDER MARGARET A. now holds 73,406 shares worth roughly $31564.579999999998.
Then, Rona Jeffrey A sold 3,902 shares, generating $2,185 in total proceeds. Upon selling the shares at $0.56, the CBFO now owns 67,973 shares.
Before that, ALEXANDER MARGARET A. bought 6,810 shares. Ovid Therapeutics Inc shares valued at $4,971 were divested by the President and COO at a price of $0.73 per share. As a result of the transaction, ALEXANDER MARGARET A. now holds 34,935 shares, worth roughly $15022.05.
Oppenheimer downgraded its Ovid Therapeutics Inc [OVID] rating to a Perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in late April with a ‘”a Buy”‘ rating. H.C. Wainwright began covering OVID with “Buy” recommendation on April 29, 2024. Wedbush started covering the stock on April 05, 2024. It rated OVID as “an Outperform”.
Price Performance Review of OVID
On Tuesday, Ovid Therapeutics Inc [NASDAQ:OVID] saw its stock jump 14.97% to $0.43. Over the last five days, the stock has gained 30.34%. Ovid Therapeutics Inc shares have fallen nearly -42.80% since the year began. Nevertheless, the stocks have fallen -53.95% over the past one year. While a 52-week high of $1.47 was reached on 01/03/25, a 52-week low of $0.24 was recorded on 04/09/25.
Levels Of Support And Resistance For OVID Stock
The 24-hour chart illustrates a support level at 0.3977, which if violated will result in even more drops to 0.3653. On the upside, there is a resistance level at 0.4562. A further resistance level may holdings at 0.4823.
How much short interest is there in Ovid Therapeutics Inc?
A steep rise in short interest was recorded in Ovid Therapeutics Inc stocks on 2025-06-13, growing by 0.87 million shares to a total of 2.5 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 1.63 million shares. There was a rise of 34.81%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 21, 2023 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $11 price target.
